These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 10414394)
1. Comparison of formoterol, salbutamol and salmeterol in methacholine-induced severe bronchoconstriction. Politiek MJ; Boorsma M; Aalbers R Eur Respir J; 1999 May; 13(5):988-92. PubMed ID: 10414394 [TBL] [Abstract][Full Text] [Related]
2. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists. van der Woude HJ; Winter TH; Aalbers R Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351 [TBL] [Abstract][Full Text] [Related]
3. Relief of dyspnoea by beta2-agonists after methacholine-induced bronchoconstriction. van der Woude HJ; Postma DS; Politiek MJ; Winter TH; Aalbers R Respir Med; 2004 Sep; 98(9):816-20. PubMed ID: 15338791 [TBL] [Abstract][Full Text] [Related]
4. Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction. van der Woude HJ; Boorsma M; Bergqvist PB; Winter TH; Aalbers R Pulm Pharmacol Ther; 2004; 17(2):89-95. PubMed ID: 15123230 [TBL] [Abstract][Full Text] [Related]
5. A high dose of albuterol does not overcome bronchoprotective subsensitivity in asthmatic subjects receiving regular salmeterol or formoterol. Lipworth BJ; Aziz I J Allergy Clin Immunol; 1999 Jan; 103(1 Pt 1):88-92. PubMed ID: 9893190 [TBL] [Abstract][Full Text] [Related]
6. Onset of relief of dyspnoea with budesonide/formoterol or salbutamol following methacholine-induced severe bronchoconstriction in adults with asthma: a double-blind, placebo-controlled study. Jonkers RE; Bantje TA; Aalbers R Respir Res; 2006 Dec; 7(1):141. PubMed ID: 17144916 [TBL] [Abstract][Full Text] [Related]
7. Acute protection against exercise-induced bronchoconstriction by formoterol, salmeterol and terbutaline. Richter K; Janicki S; Jörres RA; Magnussen H Eur Respir J; 2002 May; 19(5):865-71. PubMed ID: 12030726 [TBL] [Abstract][Full Text] [Related]
8. Inhaled dry-powder formoterol and salmeterol in asthmatic patients: onset of action, duration of effect and potency. Palmqvist M; Persson G; Lazer L; Rosenborg J; Larsson P; Lötvall J Eur Respir J; 1997 Nov; 10(11):2484-9. PubMed ID: 9426083 [TBL] [Abstract][Full Text] [Related]
9. In vivo effect of albuterol on methacholine-contracted bronchi in conjunction with salmeterol and formoterol. Aziz I; Lipworth BJ J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):816-22. PubMed ID: 10329815 [TBL] [Abstract][Full Text] [Related]
10. Dose-related efficacy and safety of formoterol (Oxis) Turbuhaler compared with salmeterol Diskhaler in children with asthma. Pohunek P; Matulka M; Rybnícek O; Kopriva F; Honomichlová H; Svobodová T Pediatr Allergy Immunol; 2004 Feb; 15(1):32-9. PubMed ID: 14998380 [TBL] [Abstract][Full Text] [Related]
11. Functional antagonism with formoterol and salmeterol in asthmatic patients expressing the homozygous glycine-16 beta(2)-adrenoceptor polymorphism. Lipworth BJ; Dempsey OJ; Aziz I Chest; 2000 Aug; 118(2):321-8. PubMed ID: 10936119 [TBL] [Abstract][Full Text] [Related]
12. Comparison of combination inhalers vs inhaled corticosteroids alone in moderate persistent asthma. Lee DK; Jackson CM; Currie GP; Cockburn WJ; Lipworth BJ Br J Clin Pharmacol; 2003 Nov; 56(5):494-500. PubMed ID: 14651722 [TBL] [Abstract][Full Text] [Related]
13. Influence of beclomethasone and salmeterol on the perception of methacholine-induced bronchoconstriction. Boulet LP; Turcotte H; Cartier A; Milot J; Côté J; Malo JL; Laviolette M Chest; 1998 Aug; 114(2):373-9. PubMed ID: 9726717 [TBL] [Abstract][Full Text] [Related]
14. Protective effect of budesonide/formoterol compared with formoterol, salbutamol and placebo on repeated provocations with inhaled AMP in patients with asthma: a randomised, double-blind, cross-over study. Aalbers R; Boorsma M; van der Woude HJ; Jonkers RE Respir Res; 2010 May; 11(1):66. PubMed ID: 20509942 [TBL] [Abstract][Full Text] [Related]
15. Unaltered perception of dyspnoea during treatment with long-acting beta2-agonists. van der Woude HJ; Aalbers R Eur Respir J; 2001 Aug; 18(2):269-71. PubMed ID: 11529283 [TBL] [Abstract][Full Text] [Related]
16. Formoterol and salmeterol in partially reversible chronic obstructive pulmonary disease: A crossover, placebo-controlled comparison of onset and duration of action. Celik G; Kayacan O; Beder S; Durmaz G Respiration; 1999; 66(5):434-9. PubMed ID: 10516540 [TBL] [Abstract][Full Text] [Related]
17. Reversing acute bronchoconstriction in asthma: the effect of bronchodilator tolerance after treatment with formoterol. Jones SL; Cowan JO; Flannery EM; Hancox RJ; Herbison GP; Taylor DR Eur Respir J; 2001 Mar; 17(3):368-73. PubMed ID: 11405513 [TBL] [Abstract][Full Text] [Related]
18. Acute bronchodilatory effect of salmeterol on methacholine-induced bronchoconstriction in childhood asthma. Baki A; Karagüzel G Acta Paediatr Jpn; 1998 Apr; 40(2):135-7. PubMed ID: 9581303 [TBL] [Abstract][Full Text] [Related]
19. Onset of bronchodilation of budesonide/formoterol vs. salmeterol/fluticasone in single inhalers. Palmqvist M; Arvidsson P; Beckman O; Peterson S; Lötvall J Pulm Pharmacol Ther; 2001; 14(1):29-34. PubMed ID: 11162416 [TBL] [Abstract][Full Text] [Related]
20. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol. Kalra S; Swystun VA; Bhagat R; Cockcroft DW Chest; 1996 Apr; 109(4):953-6. PubMed ID: 8635376 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]